PLG and breast cancer: Since in the absence of cells, plasmin had no collagenolytic activity (see legend to Figures 1 and 2) and none of these inhibitors was cytotoxic, (data not shown), these results showed that bone collagen degradation by human breast cancer cells is dependent upon plasminogen activation and MMP activity.